Denim

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Denim

What is Denim? (Nimesulide: Identity and Classification)

Here is a quick overview of the essential facts about the medicine Denim.

Property Description
Active ingredient Nimesulide
Form Tablet, Granules, Topical Gel
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
Common use Symptomatic relief of pain, inflammation, and fever
Origin Synthetic organic compound

Defining the Active Ingredient and Nature

The medicine known by the trade name Denim contains the single active ingredient, Nimesulide, which is primarily utilized for its anti-inflammatory, analgesic, and antipyretic properties. Nimesulide is classified as a synthetic organic compound, specifically a derivative of the sulfonanilide structure. It is available for both systemic and local administration, most commonly found as an oral tablet or granules for oral suspension, and as a topical gel.

Nimesulide is used for providing short-term symptomatic relief, such as easing discomfort associated with acute pain. As a non-steroidal anti-inflammatory drug, Nimesulide is utilized for the reduction of acute pain and inflammation. The medicine is designed to provide relief by targeting the body’s inflammatory response.


Classification and General Purpose

Nimesulide belongs to the major therapeutic category of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). It is further scientifically classified as a cyclooxygenase-2 (COX-2) selective inhibitor, distinguishing its mechanism within the broader NSAID group. This relative selectivity is a key feature, as this mechanism is utilized to manage the inflammatory component of conditions while offering pain relief.

The general purpose of Denim is to provide symptomatic relief by leveraging this selective mechanism. Nimesulide acts predominantly as a selective inhibitor of cyclooxygenase-2. This capability ensures the drug addresses the overall physiological response, serving as an anti-inflammatory agent, analgesic, and antipyretic.

Regulatory References

  1. Nimesulide - referral | European Medicines Agency

What side effects are possible with Denim?

Possible Side Effects and Safety Information

Denim is associated with an official safety profile that includes documented adverse reactions and significant limitations, primarily concerning the gastrointestinal and hepatobiliary systems. As with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), its use is restricted in specific high-risk populations.

Adverse Reactions

Commonly reported side effects involve the gastrointestinal system (nausea, vomiting, diarrhea, stomach discomfort) and the hepatobiliary system (increased liver enzymes).

Serious Adverse Reactions and long-term risks include stomach bleeding/ulceration and kidney problems, particularly with extended use. Severe complications such as liver failure and severe skin reactions have been documented.

Safety Restrictions and Contraindications

Safety Consideration Regulatory Status
Pregnancy Contraindicated / Highly unsafe; carries a risk of birth defects and fetal/neonatal kidney failure.
Liver Disease Contraindicated / Unsafe; should be avoided due to the risk of severe liver injury.
Children Contraindicated for children under 12 years of age by some regulatory authorities.
Severe Kidney Disease Use with Caution; dose adjustment is typically required.
Alcohol Unsafe; concurrent use increases the risk of stomach problems and gastrointestinal bleeding.

Long-term treatment with this medicine necessitates the regular monitoring of the patient’s liver function, kidney function, and blood component levels. Patients with a history of heart disease, stroke, or blood clotting disorders require specific caution and close medical supervision during therapy.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for a Denim (Nimesulide) overdose details both common acute manifestations and serious potential outcomes. Acute overdose often presents with general symptoms, including nausea, vomiting, and epigastric pain. More severe effects that may be observed include lethargy and drowsiness.

The documented potential for rare, serious complications includes gastrointestinal bleeding, acute renal failure, respiratory depression, and coma. Individuals who have taken an overdose are required by regulatory guidance to seek immediate medical attention for assessment and management.

Management and Monitoring

This urgent need for care is underscored by the lack of a known specific antidote. Therefore, the management procedures detailed in official labeling are focused exclusively on providing symptomatic and supportive care. Management options listed include the potential use of activated charcoal if the ingestion occurred within the initial hours.

Patients with pre-existing conditions, such as hepatic impairment or severe renal impairment, are noted in regulatory documents as populations requiring heightened vigilance due to an increased risk of severe complications in an overdose scenario.

Therapeutic Uses of Denim

What Denim Treats: Main Uses and Benefits

Denim (Nimesulide) is applied across domains where additional symptomatic support is needed in situations where symptoms related to inflammatory or irritative states create noticeable physiological strain. It is a medication commonly used to help with providing symptomatic relief across a spectrum of acute conditions where pain, inflammation, and fever cluster together. The systemic use of the medication is indicated for specific conditions.

Management of Acute Pain and Inflammation

This domain helps address symptom clusters that may become intense or disruptive, such as the pain and swelling resulting from minor traumatic injuries, general aches like backache or headache when associated with an acute inflammatory state, and post-operative discomfort. Its role involves managing multiple symptoms together, which contributes to improved comfort during periods of heightened symptoms.

Support for Specific Musculoskeletal and Gynecological Discomfort

Denim is relevant in conditions characterized by periods of heightened symptoms such as the pain and acute discomfort of primary dysmenorrhea (menstrual cramps). It is also commonly used to help with recurrent, symptomatic flare-ups related to osteoarthritis where short-term assistance is needed. This application may provide supportive relief when symptoms interfere with routine activities.


Quick Fact: Managing Symptoms: Pain, Inflammation, and Fever

The medication is commonly used to help manage symptoms such as those found in acute pain episodes, primary dysmenorrhea, and short-term symptomatic relief in painful osteoarthritic conditions.

Eligibility and Restrictions for Use

Who can and cannot use Denim? (Nimesulide)

The population eligibility for Denim (Nimesulide) is strictly defined by regulatory authorities and focuses on specific age, organ function, and medical history criteria.

Contraindications and Restrictions

Denim is strictly contraindicated in several populations. It must not be used in children under 12 years of age or in patients with any degree of hepatic impairment, severe renal impairment (creatinine clearance less than 30 ml/min), or severe heart failure. Use is also prohibited in those with active gastric or duodenal ulcers, a history of recurrent gastrointestinal bleeding, or severe coagulation disorders.

Age-Group Eligibility Status as per Labeling
Children (< 12 years) Contraindicated
Adolescents (12–18 years) Permitted for labeled indications
Older Adults Permitted, but requires caution and clinical monitoring

Additionally, the medicine is contraindicated during the third trimester of pregnancy and is generally not recommended while breastfeeding. Patients with mild to moderate renal impairment are permitted to use the medicine but require caution and careful consideration, as do individuals with uncontrolled hypertension or a history of pre-existing cardiovascular conditions.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documentation structures the interaction profile of Denim (Nimesulide) around specific pharmacokinetic and pharmacodynamic constraints.

Documented Interaction Patterns

Category Officially Documented Constraint
Contraindicated Combinations Co-administration with other potentially hepatotoxic substances is formally restricted. Use is prohibited in patients with a history of alcohol abuse or alcoholism.
Metabolic Interactions Nimesulide is documented as an inhibitor of the CYP2C9 enzyme. This action may increase the plasma concentration of co-administered drugs that are substrates of this pathway.
Pharmacodynamic Interactions The combination with anticoagulant agents (such as Warfarin) is not recommended due to an officially documented increased risk of bleeding.
Exposure Modification Co-use may reduce the clearance of Lithium, leading to elevated plasma concentrations. Nimesulide reduces the diuretic effect of Furosemide, decreasing its excretion.
Timing Requirements Caution is advised if Methotrexate is administered less than 24 hours before or after Nimesulide treatment.

Interaction Context

Regulatory documents emphasize specific cautions for vulnerable populations: co-administration with Furosemide requires caution in patients susceptible to renal or cardiac impairment. Use with Cyclosporine may lead to an increased risk of nephrotoxicity.

Mechanism of Action

The action involves the modulation of specific enzymes within the arachidonic acid cascade.

Selective Blockade of the COX-2 Enzyme

The primary mechanism of action involves acting as a selective inhibitor of the Cyclooxygenase-2 ( COX-2) enzyme. This enzyme is the key target that produces chemical messengers responsible for driving heightened physiological responses. By binding to and blocking COX-2, the drug initiates a cascade that suppresses the activity of these pathways.

Modulating Prostaglandin Signaling and PGE2 Effects

Blocking the COX-2 enzyme directly limits the synthesis of Prostaglandin E2 ( PGE2), a key mediator of nociception, thermoregulation, and vascular permeability. This chemical reduction affects systems in both peripheral tissues and the central nervous system, resulting in a reduction of nociceptor sensitization and the modulation of the hypothalamic temperature set-point.

Mechanistic Constraints and Selectivity

The functional mechanism is constrained by the principle of dose-dependent selectivity; while it preferentially targets COX-2, higher molecular concentrations can lead to increased interaction with the homeostatic COX-1 enzyme. The overall physiological impact is confined to modulating physiological responses and does not address structural changes or the immunological progression of the condition.

Dosage and Administration Information

Denim, a medication containing the non-steroidal anti-inflammatory drug (NSAID) nimesulide, must be used exactly as prescribed by a healthcare provider. The drug is typically administered as an oral tablet or suspension.

General Administration Guidelines

Administration Aspect Instruction
Dosage and Duration Use the lowest effective dose for the shortest possible duration to manage symptoms, as prolonged use may increase the risk of adverse effects. Do not exceed the prescribed dose or treatment length.
With Food It is commonly advised to take Denim with or after food to minimize the potential for gastrointestinal upset, as is common with NSAIDs.
Swallowing Swallow the tablet whole with a glass of water. Do not crush, chew, or break it, unless specifically instructed by your pharmacist or physician.
Fixed Schedule For optimal results and consistent pain management, take the medicine at a fixed time each day, if prescribed for regular dosing.

Missed and Overdosed Doses

If a dose is missed, take it as soon as it is remembered. However, if it is close to the time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. Do not double the dose to compensate for a missed one. An accidental overdose may cause symptoms such as nausea, vomiting, drowsiness, or abdominal pain; in such an event, seek emergency medical attention immediately.

Note on Population Use: Denim (nimesulide) is generally not recommended for use in children under 12 years of age. Patients with pre-existing conditions, particularly severe liver or kidney impairment, or a history of stomach ulcers/bleeding, should not use this medication. Always discuss all medical history and current medications with your healthcare provider before starting treatment.

Recent Clinical Evidence

Research Evidence: Overview of Studies for Denim

Evidence for Use in Type 2 Diabetes Mellitus

Research has examined Denim in adults with Type 2 Diabetes, conditions marked by functional limitations related to blood glucose control. Studies explored how the compound was studied in participants whose glucose levels were inadequately controlled despite existing treatments, such as metformin. The evidence is derived primarily from randomized controlled trials (RCTs) covering short-term periods and intermediate periods up to two years.

Researchers measured outcomes related to systemic or functional imbalance, specifically focusing on key blood glucose markers like glycated hemoglobin (A1C), fasting plasma glucose (FPG), and postprandial glucose (PPG). Findings describe patterns observed in these measured outcomes, as well as changes in body weight and blood pressure, across the observed populations. Evidence highlights what is known so far about these short-term changes, but the long-term picture remains a focus for continuing research.


Evidence for Use in Chronic Kidney Disease and Cardiovascular Risk Reduction

Denim was evaluated in populations presenting with conditions marked by functional limitations of the kidneys, specifically adults with Type 2 Diabetes and established Chronic Kidney Disease (CKD). The research focused on dedicated RCTs and evaluated specific outcomes related to kidney health, such as changes in estimated glomerular filtration rate (eGFR) and the urine albumin-to-creatinine ratio (UACR).

Research also explored the compound's activity in populations at high risk for cardiovascular events. These large-scale, event-driven trials examined the frequency of Major Adverse Cardiovascular Events (MACE), including non-fatal heart attacks and strokes, in adults with Type 2 Diabetes and established cardiovascular risk factors. The results apply only to the specific high-risk populations studied. Comparative evidence against all alternatives is generally lacking, and the long-term stability of the measurements observed over many years is not fully established.

Frequently Asked Questions (FAQ)

Common questions about Denim (FAQ)


Q: Does Denim interact with common over-the-counter pain relievers?

Official interaction information indicates that combining Denim with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) or medications like acetaminophen can increase the risk of adverse effects. Regulatory documentation indicates that co-administration of these substances is generally not recommended or is restricted.


Q: What is the eligibility criteria for being prescribed Denim?

Regulatory guidelines restrict the use of Denim to specific, limited conditions. It is designated as a second-line treatment option for acute pain, painful osteoarthritis, and primary dysmenorrhoea (menstrual pain). The maximum treatment duration for any single course is officially limited to 15 days.


Q: Does Denim cause weight changes?

According to the official product information, potential undesirable effects include fluid retention and swelling, known as edema. These fluid changes are listed as potentially leading to weight gain in some cases.


Q: What is the mechanism of action of Denim in simple terms?

The medicine is described as working by acting as a preferential inhibitor of the COX-2 enzyme. This enzyme produces chemical messengers that cause inflammation and pain signals. By preferentially blocking COX-2, the drug helps to modulate these processes.


Q: Is the research evidence for Denim strong or limited?

The regulatory approach to this drug reflects its safety profile and risk management. Official restrictions mandate that it must be used at the lowest possible dose for the shortest duration (maximum 15 days). It is also required to be used only as a second-line treatment, which places official limits on its general use.


Q: What should a patient do if they experience a rare but serious side effect listed?

Official warnings emphasize the importance of monitoring for symptoms of serious hepatic injury, such as extreme fatigue or dark urine, or signs of gastrointestinal bleeding. Official documentation states that if these symptoms occur, the medication is typically required to be immediately discontinued and subsequent use is prohibited.


Q: How does Denim affect blood pressure?

High blood pressure, known as hypertension, is listed as an uncommon undesirable effect in the official product information. Patients with pre-existing heart conditions or hypertension are identified in safety warnings as requiring close medical supervision during therapy.


Q: What official body approved Denim?

The drug has undergone regulatory assessment by the European Medicines Agency (EMA), and its authorizations have been renewed by this body. Denim is licensed and available for use in over 50 countries worldwide, reflecting its global regulatory status.


Q: How quickly does Denim usually start working?

Studies and clinical data indicate that the medication typically has a rapid onset of analgesic effect. Pain reduction is commonly reported within a short time, often ranging from 15 minutes to an hour after the medicine is taken orally.


Q: What is the typical time frame to see the full effect of Denim?

Official guidelines restrict the duration of any single course of treatment to a maximum of 15 days. This regulatory limit governs the time frame within which clinically relevant effects are expected to be achieved.


Q: Are there any specific foods that interact with Denim?

Yes, official product information includes warnings regarding certain foods. Regulatory guidance advises that dairy products, such as milk, yogurt, or drinks containing added calcium, may reduce the absorption of the active ingredient, and advises against their consumption.


Q: Is it normal to feel tired in the first week of taking Denim?

Regulatory documents list somnolence, a term for drowsiness, as a potential undesirable effect. Fatigue is also noted as a potential symptom of a rare, serious event like liver injury, where the medication is required to be discontinued.


Q: Is Denim generally safe for women of childbearing age?

Official regulatory documents contain specific warnings for this population. The product information advises that the medication may impair female fertility and is therefore not recommended for women who are actively attempting to conceive.


Q: How long after stopping Denim does it stay in your system?

Pharmacokinetic data, found in the official documents, describes how long the drug remains in the body. The mean elimination half-life of the active ingredient in plasma ranges from approximately 1.8 to 4.7 hours.


Q: Are there any black box warnings associated with Denim?

Yes, some national regulatory authorities have mandated an official 'Box Warning' on the drug's packaging. This warning typically restricts the maximum duration of use and recommends periodic monitoring of liver function for patients on longer courses.


Q: Does taking Denim affect sleep patterns?

Sleep-related changes are listed among the possible undesirable effects. Regulatory documents specifically include both insomnia (difficulty sleeping) and somnolence (drowsiness).


Q: What is the risk of dependence or addiction with Denim?

The active ingredient in this medication is not classified as habit-forming. However, a history of drug addiction or chronic alcoholism is listed as a formal contraindication, meaning the drug is prohibited for use in these individuals.


Q: Are there warnings about driving or operating machinery while on Denim?

Yes, official product information includes warnings regarding these activities. Patients who experience undesirable effects such as dizziness, vertigo, or somnolence (drowsiness) are advised to refrain from driving or operating machinery.


Q: How long have people been using Denim globally?

According to clinical and regulatory timelines, the medication has a long history of use. The active ingredient has been widely available on the global market and prescribed since 1985.

How should Denim be stored and disposed of?

Official Storage and Disposal Requirements

The storage and disposal of Denim (Nimesulide) must strictly follow the conditions mandated in the official regulatory product information to ensure stability and safety.

Storage Conditions

Requirement Category Official Requirement
Temperature Store below 30°C.
Protection Keep in original container, tightly closed, and protect from moisture and direct sunlight.
Child Safety Keep out of the sight and reach of children (Store locked up).

Disposal Instructions

Unused or expired Denim must be disposed of according to local regulations for pharmaceutical waste. The product must not be disposed of in wastewater or released into the environment, as specified in handling guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Denim found in:

A-Z Index: